Metabolic factor-based machine learning model for mortality prediction in acute hepatitis E: Development and
Haoshuang Fu1, Shuying Song1, Yuelin Xiao1
1Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Summary
A new logistic regression model accurately predicts short-term mortality in Hepatitis E virus (HEV) patients using metabolic factors. This model aids in early risk stratification and personalized management for HEV infection.
Area of Science:
- Hepatology
- Machine Learning in Medicine
- Predictive Modeling
Background:
- Hepatitis E virus (HEV) infection is a significant cause of liver failure with high mortality.
- Existing predictive models for HEV lack comprehensive systemic metabolic factors.
Purpose of the Study:
- To develop a machine learning model for predicting mortality in HEV patients.
- To integrate systemic metabolic parameters into a predictive model for HEV.
Main Methods:
- Retrospective analysis of 510 HEV patients across training, internal, and external validation cohorts.
- Development of a Metabolism Score using Support Vector Machines (SVM) with metabolic parameters.
- Selection of clinical variables and the Metabolism Score using LASSO regression.
- Construction and evaluation of five machine learning models for 28-day and 90-day mortality prediction.
Main Results:
- Logistic Regression (LR) model demonstrated superior performance in predicting 28-day and 90-day mortality across all cohorts (AUROCs ranging from 0.84 to 0.98).
- The LR model outperformed the MELD score in predictive accuracy.
- The developed LR model showed good calibration, significant net clinical benefits, and was visualized using a nomogram.
Conclusions:
- The LR model incorporating systemic metabolic factors provides accurate prediction of short-term mortality in HEV patients.
- This model can potentially enhance early risk stratification and guide personalized treatment strategies for HEV infection.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
225
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
225
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
338
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
338


